Personalization is fundamental, not an edge case
The guest argued that the mRNA cancer vaccine's efficacy is intrinsically tied to personalization, as roughly 90% of the selected antigens differ from patient to patient, making a one-size-fits-all shared antigen approach ineffective.
Keep reading this one
You've read the thesis and who argued it. A free account opens the argument, what validates it, the risks the show raised, and the moment in the episode where it was said — 3 ideas in full a day, no card.